Insite Vision Inc's ability to collect accounts receivable sequentially worsen to 12.54, indicating more challenging environment then in the first quarter 2015, but still, it is a far cry from any concerns. Insite Vision Inc's Accounts Receivable average collection period in the Jun 30 2015 quarter, has increased to 29 days, from 13 days, in the Mar 31 2015 quarter.

If we take a look into Healthcare sector 46 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 963, from overall ranking in the first quarter 2015 at 1108.

What is Receivable Turnover Ratio?
What is Insite Vision Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

INSV Receivables Turnover Ratio	(Jun 30 2015) II. Quarter	(Mar 31 2015) I. Quarter	(Dec 31 2014) IV. Quarter	(Sep 30 2014) III. Quarter	(Jun 30 2014) II. Quarter
Y / Y Receivable Change	-12.5 %	-79.82 %	-83.69 %	-92.42 %	-91.41 %
Y / Y Revenue Change	-93.83 %	192.8 %	-67.04 %	-93.15 %	-67 %
Receivable Turnover Ratio (TTM)	12.54	28.21	11.27	7.59	6.08
INSV's Total Ranking	# 963	# 1108	# 1108	# 1108	# 962
Accounts Receivable average collection period days	29	13	32	48	60
Seq. Receivable Change	-1.65 %	4.01 %	-3.06 %	-11.76 %	-77.32 %
Seq. Revenue Change	-88.39 %	859.09 %	-2.22 %	-94.33 %	450.65 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 24
Healthcare Sector	# 47
Overall Market	# 963

Receivable Turnover Ratio Statistics
High	Average	Low
28.21	10.24	4.12
(Mar 31 2015)		(Dec 31 2012)

INSV Company Profile • Back to INSV Efficiency Comparisons • Compare INSV Receivables Turnover Ratio to its Competitors

Financial Statements
Insite Vision Inc's Accounts Receivable	$ 0 Millions	Visit INSV's Balance sheet
Insite Vision Inc's Sales TTM	$ 4 Millions	Visit INSV's Income Statement
Sources of INSV's Revenues		Visit INSV's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
INSV's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
INSV's Growth Rates	INSV's Roa	INSV's Inventory Turnover Ratio	INSV's Dividend Comparisons
INSV's Profitability Ratios	INSV's Roi	INSV's Asset Turnover Ratio	INSV's Dividend Growth
INSV's Valuation Ratios	INSV's Roe	INSV's Financial Strength Ratios	INSV's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2015, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2015	Receivable at quarter ending Jun 30 2015
Advanced Container Technologies Inc	32.64	$ 1.005 Millions	$ 0.031 Millions
Brookdale Senior Living Inc	31.94	$ 4,822.103 Millions	$ 150.997 Millions
Macrogenics Inc	28.48	$ 101.853 Millions	$ 3.576 Millions
Cyteir Therapeutics Inc	25.81	$ 2,014.800 Millions	$ 78.050 Millions
Immunogen inc	25.53	$ 85.541 Millions	$ 3.350 Millions
Ernexa Therapeutics Inc	23.38	$ 24.674 Millions	$ 1.055 Millions
Glucotrack Inc	22.79	$ 0.386 Millions	$ 0.017 Millions
U s Stem Cell Inc	21.50	$ 2.291 Millions	$ 0.107 Millions
Wearable Health Solutions, Inc.	21.49	$ 1.147 Millions	$ 0.053 Millions
Pacific Biosciences Of California Inc	21.34	$ 80.111 Millions	$ 3.753 Millions
Ardelyx inc	20.76	$ 37.962 Millions	$ 1.829 Millions
Ionis Pharmaceuticals Inc	20.65	$ 311.935 Millions	$ 15.104 Millions
Nektar Therapeutics	20.19	$ 283.884 Millions	$ 14.061 Millions
Aspira Women s Health inc	20.14	$ 3.378 Millions	$ 0.168 Millions
Vivosim Labs Inc	19.21	$ 0.778 Millions	$ 0.041 Millions
Miragen Therapeutics Inc	17.81	$ 4.425 Millions	$ 0.249 Millions
Biocept Inc	17.69	$ 0.313 Millions	$ 0.018 Millions
Veracyte Inc	17.40	$ 45.163 Millions	$ 2.595 Millions
International Stem Cell Corporation	16.84	$ 7.217 Millions	$ 0.429 Millions
Cyclo Therapeutics Inc	16.21	$ 1.387 Millions	$ 0.086 Millions
Pacira Biosciences inc	16.02	$ 367.180 Millions	$ 22.919 Millions
Adma Biologics Inc	15.89	$ 7.228 Millions	$ 0.455 Millions
Sunlink Health Systems Inc	15.73	$ 85.285 Millions	$ 5.423 Millions
Harrow Inc	15.53	$ 4.521 Millions	$ 0.291 Millions
United Cannabis Corp	15.31	$ 0.589 Millions	$ 0.038 Millions
Epizyme Inc.	15.31	$ 20.173 Millions	$ 1.318 Millions
Acorda Therapeutics Inc	14.91	$ 437.391 Millions	$ 29.338 Millions
Apyx Medical Corp	14.80	$ 27.656 Millions	$ 1.869 Millions
Coherus Oncology inc	14.77	$ 35.221 Millions	$ 2.385 Millions
Caredx Inc	14.59	$ 28.951 Millions	$ 1.984 Millions

Date modified: 2026-08-29T17:23:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.